Intel debuts its 2nd Generation Intel Core Processors. Based on Intel's cutting-edge 32-nanometer process technology, the new chips feature the company's first "visibly smart" micro-architecture to combine visual and 3-D graphics technology with performance-leading microprocessors on a single chip. Intel

Lonza has chosen IDBS to provide an electronic data management and execution solution for mammalian cell culture process development. The biopharma will deploy IDBS’s Bioprocess Execution System to optimize the management of process development data and drive operational excellence to Lonza customers. Lonza 

The Wellcome Trust Sanger Institute has purchased an Argus Optical Mapping System by OpGen. The Mapping and Archive Sequencing Division at the Sanger Institute plans to begin Optical Mapping of bacteria and parasites in January 2011. OpGen

Thomson Reuters and ChemAxon have announced a strategic partnership whereby Thomson Reuters is providing its chemical IP Data Feeds – Markush Structures and patent data to users of ChemAxon’s JChem chemical software platform. This search and analysis solution will speed drug discovery and allow life science researchers to easily integrate critical content into their existing systems and workflow. Thomson Reuters  

Chemical Abstracts Service has made time-saving advancements and usability improvements to SciFinder, its premier research and discovery tool. The enhancements will accelerate researchers’ workflow and are especially valuable for synthetic chemists and other researchers who are engaged in lab preparations and synthesis planning. SciFinder Demo

EdgeBio has been appointed Certified Service Provider (CSP) for the Agilent SureSelect Target Enrichment System for next-generation sequencing. SureSelect, introduced in February 2009, has been shown to greatly increase the speed and cost-efficiency of next-generation sequencing workflows by enabling experiments to focus on genomic regions of interest rather than sequencing the entire genome. EdgeBio achieved SureSelect CSP status for the Life Technologies SOLiD 4 sequencing platform after completing training and demonstrating proficiency with the target enrichment system. Agilent  

Source BioScience LifeSciences has acquired imaGenes of Berlin. imaGenes is a provider of genome research services and products in Europe, managing a comprehensive clone collection and offering an exciting range of services including microarray, protein arrays and DNA sequencing. Source BioScience hopes that imaGenes’ high end bioinformatic expertise will complement the group’s investment in leading edge next generation sequencing. Source BioScience